JP2025520225A5 - - Google Patents
Info
- Publication number
- JP2025520225A5 JP2025520225A5 JP2024568439A JP2024568439A JP2025520225A5 JP 2025520225 A5 JP2025520225 A5 JP 2025520225A5 JP 2024568439 A JP2024568439 A JP 2024568439A JP 2024568439 A JP2024568439 A JP 2024568439A JP 2025520225 A5 JP2025520225 A5 JP 2025520225A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- gene
- promoter
- cell
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263343537P | 2022-05-18 | 2022-05-18 | |
| US63/343,537 | 2022-05-18 | ||
| US202363498202P | 2023-04-25 | 2023-04-25 | |
| US63/498,202 | 2023-04-25 | ||
| PCT/US2023/066760 WO2023225447A1 (en) | 2022-05-18 | 2023-05-09 | Production and/or delivery of multispecific binding agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025520225A JP2025520225A (ja) | 2025-07-02 |
| JP2025520225A5 true JP2025520225A5 (enExample) | 2026-06-02 |
Family
ID=88836233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024568439A Pending JP2025520225A (ja) | 2022-05-18 | 2023-05-09 | 多重特異性結合剤の製造および／または送達 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250369020A1 (enExample) |
| EP (1) | EP4526458A1 (enExample) |
| JP (1) | JP2025520225A (enExample) |
| AU (1) | AU2023273018A1 (enExample) |
| CA (1) | CA3256784A1 (enExample) |
| WO (1) | WO2023225447A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026090418A1 (en) * | 2024-10-24 | 2026-04-30 | University Of Massachusetts | Ultra-efficient rna switches and related expression systems |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3945800A1 (en) * | 2019-04-03 | 2022-02-09 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for insertion of antibody coding sequences into a safe harbor locus |
| WO2022099297A1 (en) * | 2020-11-04 | 2022-05-12 | Fate Therapeutics, Inc. | Multiplexed engineered ipsc and immune effector cells targeting solid tumors |
-
2023
- 2023-05-09 JP JP2024568439A patent/JP2025520225A/ja active Pending
- 2023-05-09 EP EP23808469.3A patent/EP4526458A1/en active Pending
- 2023-05-09 CA CA3256784A patent/CA3256784A1/en active Pending
- 2023-05-09 US US18/864,832 patent/US20250369020A1/en active Pending
- 2023-05-09 AU AU2023273018A patent/AU2023273018A1/en active Pending
- 2023-05-09 WO PCT/US2023/066760 patent/WO2023225447A1/en not_active Ceased